Benign paroxysmal positional vertigo
Conditions
Interventions
experimental group:Vitamin D2 injection 200,000U, Intramuscular injection monthly
control group :No intervention
Sponsors
Gansu Provincial Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. In line with the BPPV diagnostic criteria of the Otolaryngology Branch of the Chinese Medical Association (a positive Dix-Hallpike test is diagnosed as vertical semicircular canal BPPV, and a positive horizontal rolling test is diagnosed as horizontal semicircular canal BPPV, all of which are idiopathic BPPV, aged >= 18 and <= 80 years; 2. Vitamin D deficiency was diagnosed on the day of consultation (25(OH)D<20 ng/ml); 3. Signe the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Combined with other peripheral vertigo diseases or central vertigo diseases; 2. History of infectious diseases; 3. Combined with allergic diseases; 4. Combined with chronic blood system disease, kidney disease, intestinal disease, severe cardiovascular system disease, or central nervous system disease; 5. History of taking drugs that affect Vitamin D metabolism; 6. Pregnant women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum 25(OH)D level;recurrence of benign paroxysmal positional vertigo;serum calcium ion; | — |
Countries
China
Contacts
Public ContactYang Zhiling
Gansu Provincial Hospital
Outcome results
None listed